Skip to main content
Log in

Unrelated and related cord blood banking and hematopoietic graft engineering

  • Published:
Cell and Tissue Banking Aims and scope Submit manuscript

Abstract

The first successful transplantation of umbilical-cord blood (CB) was performed in 1988 to treat a boy with Fanconi's anemia, using CB from his HLA full-matched sister. A few years later, CB transplantation (CBT) was also performed in an adult recipient, however major obstacles still prevent a wider application of CBT in this age group. The principle limiting-factor is the low numbers of nucleated (NC) and CD34+ cells available for transplantation compared to a typical bone marrow (BM)/peripheral blood (PB) allograft, resulting in a lower engraftment success as well as delayed hematopoietic recovery with its characteristic complications, including infections and transplant related mortality (TRM). Other problems include uncertainty regarding potency and efficacy of graft versus leukemia (GvL)/tumor effects in this kind of transplant, considering the reduced graft versus host disease (GvHD) manifestations and immunologic prematurity. These subjects are reviewed with orientation to technical methods directed to improve CB grafts and graft engineering.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ameen R.M., Lowdall M.W., AL-Shemmari S.H. and Navarrete C. 2001. Differential cytotoxic pathways in cord blood natural killer cell: Implications on anti-leukemia effect in cord blood transplantation. Blood 98(11): abstract 5227.

    Google Scholar 

  • Condiotti R. and Nagler A. 1998. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells. Experimental Hematology 26: 571–579.

    Google Scholar 

  • Condiotti R., Bar Zakai Y., Barak V. and Nagler A. 2001. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Experimental Hematology 29: 104–113.

    Google Scholar 

  • Elchalal U., Fasouliotis S.J., Shtockheim D., Brautbar C., Schenker J.G., Weinstein D. and Nagler A. 2000. Postpartum umbilical cord blood collection for transplantation: a comparison of three methods. American Journal of Obstetrics and Gynecology 182: 227–232.

    Google Scholar 

  • Fernandez M.N., Regidor C., Cabrera R., Garcia-Marco J., Briz M., Fores R., Sanjuan I., McWhinnie A., Querol S., Garcia J. and Madrigal A. 2001. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant 28: 355–363.

    Google Scholar 

  • Fischer J., Kgler G. and Wernet P. 2001. Nucleated red cell quantities and true graft cell dose in cord blood banking and transplantation: critical influence on its detection by the counting method. Blood 98(11): abstract #760.

  • Gilmore G.L., Lister J. and Shadduck R.K. 2001. Hetastarch depletion of erythrocytes inhibits ex vivo expansion of human CD34+ umbilical cord blood stem cells. Blood 98(11): abstract 2752.

    Google Scholar 

  • Gluckman E., Broxmeyer H.A., Auerbach A.D. et al. 1989. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. The New England Journal of Medicine 321: 1174–1178.

    Google Scholar 

  • Gluckman E., Rocha V., Boyer-Chammard A. et al. 1997. Outcome of cord-blood transplantation from related and unrelated donors. The New England Journal of Medicine 337: 373–381.

    Google Scholar 

  • Gluckman E. 2000. Current status of umbilical cord blood hematopoietic stem cell transplantation. Experimental Hematology 28: 1197–1205.

    Google Scholar 

  • Grisaru D., Deutsch V., Pick M., Fait G., Lessing J.B., Dollberg S. and Eldor A. 1999. Placing the newborn on the maternal abdomen after delivery increases the volume and CD34 cell content in the umbilical cord blood collected: an old maneuver with new applications. American Journal of Obstetrics and Gynecology 180: 1240–1243.

    Google Scholar 

  • Huang S.L., Mai H.R., Fang J.P., Xu H.G., Wei Q. and Huang W.G. 2001. All-trans retinoic acid up-regulates ICAM-1 expression and enhances engraftment of hematopoietic stem cells in murine model for unrelated umbilical cord blood transplantation. Blood 98(11): abstract 727.

    Google Scholar 

  • Juliet N. Barker, Daniel J. Weisdorf, Todd E. DeFor, Stella M. Davies, Catherine M. Verfaillie and John E. Wagner 2001. Impact of Multiple Unit Unrelated Donor Umbilical cord blood transplantation in Adults: Preliminary Analysis of Safety and Efficacy. Bone Marrow Transplant 28: 355–363.

    Google Scholar 

  • Kogler G., Somville T., Gobel U., Hakenberg P., Knipper A., Fischer J., Adams O., Krempe C., McKenzie C., Ruttgers H., Meier W., Bellmann O., Streng H., Ring A., Rosseck U., Rocha V. and Wernet P. 1999. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany. Klinische Padiatrie 211: 224–232.

    Google Scholar 

  • Lam A.C., Li K., Zhang X.B., Li C.K., Fok T.F., Chang A.M., James A.E., Tsang K.S. and Yuen P.M. 2001. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice. Transfusion 41: 1567–1576.

    Google Scholar 

  • Laughlin M.J., Barker J., Bambach B., et al. 2001. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. The New England Journal of Medicine 344: 1815–1822.

    Google Scholar 

  • McNiece I., Kubegov D., Kerzic P., Shpall E.J. and Gross S. 2000. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Experimental Hematology 28: 1181–1186.

    Google Scholar 

  • Migliaccio A.R., Adamson J.W., Stevens C.E., Dobrila N.L., Carrier C.M. and Rubinstein P. 2000. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 15(96): 2717–2722.

    Google Scholar 

  • Moretta A., Maccario R., Fagioli F., Giraldi E., Busca A., Montagna D., Miniero R., Comoli P., Giorgiani G., Zecca M., Pagani S. and Locatelli F. 2001. Analysis of immune reconstitution in children undergoing cord blood transplantation. Experimental Hematology 29(3): 371–379.

    Google Scholar 

  • Nagler A., Peacock M., Tantoco M., Lamons D., Okarma T.B. and Okrongly D.A. 1994. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection. Experimental Hematology 22: 1134–1140.

    Google Scholar 

  • Niehues T., Rocha V., Filipovich A.H., Chan K.W., Porcher R., Michel G., Ortega J.J., Wernet P., Gobel U., Gluckman E. and Locatelli F. 2001. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children-a Eurocord analysis. British Journal of Haematology 114: 42–48.

    Google Scholar 

  • Nolta J.A., Thiemann F.T., Arakawa-Hoyt J., Dao M.A., Barsky L.W., Moore K.A., Lemischka I.R. and Crooks G.M. 2002. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors. Leukemia 16: 352–361.

    Google Scholar 

  • Pafumi C., Milone G., Maggi I., Russo A., Farina M., Pernicone G., Bandiera S., Giardina P., Mangiafico L., Mancari R., Calogero A.E. and Cianci A. 2001. Early clamping of umbilical cord blood and foetal CD34 enrichment. Early clamping of umbilical cord blood and foetal CD34 enrichment. Acta Medica Austriaca 28: 141–144.

    Google Scholar 

  • Peled T., Landau E., Prus E., Treves A.J., Nagler A. and Fibach E. 2002. Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells. British Journal of Haematology 116: 655–661.

    Google Scholar 

  • Pick M., Nagler A., Grisaru D., Eldor A. and Deutsch V. 1998. Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two-step separation procedure. British Journal of Heamatology 103: 639–650.

    Google Scholar 

  • Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., Berkowitz R.L., Cabbad M., Dobrila N.L., Taylor P.E., Rosenfield R.E. and Stevens C.E. 1998. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. The New England Journal of Medicine 26(339): 1565–1577.

    Google Scholar 

  • Rubinstein P. and Stevens C.E. 2000. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Bailliere's Best Practice & Research Clinical Haematology 13: 565–584.

    Google Scholar 

  • Shengli Zhou, Baijun Shen, Jie Pan, Wenying Yan, Xuri and Daogang Song 2001. Umbilical cord blood banking for transplantation: The Chinese experience. Blood 98(11): abstract 5336.

    Google Scholar 

  • Stevens Z., Shi M.J., Lemerise K., Massengill J., Mackin W. and Kraus M. 2001. Pasquetto Flow cytometry and RT-PCR analysis Selectively Amplified CD45-CD34+/-CD38-Lin-cells derived from frozen human umbilical cord blood contain functional common lymphoid progenitor cells as measured by an in vitro lymphopoietic expansion assay. Blood 98(11): abstract 2750.

    Google Scholar 

  • Surbek D.V., Visca E., Steinmann C., Tichelli A., Schatt S., Hahn S., Gratwohl A. and Holzgreve W. 2000. Umbilical cord blood collection before placental delivery during cesarean delivery increases cord blood volume and nucleated cell number available for transplantation. American Journal of Obstetrics and Gynecology 183: 218–221.

    Google Scholar 

  • Szabolcs P., Park K.D., Marti L., Reese M., Broadwater G. and Kurtzberg J. 2001a. Functional T cell immunity before myeloid engraftment by donor post-thymic T cells in pediatric unrelated cord blood transplant recipients. Blood 98(11): abstract 1597.

  • Szabolcs P., Park K.D., Reese M., Marti L., Broadwater G., Niedzwiecki D., DeOliveira D. and Kurtzberg J. 2001b. Reconstitution of T cell and dendritic cell immunity 50 days post unrelated cord blood transplant predicts the incidence of opportunistic infections and acute GVHD in children. Blood 98(11): abstract 852.

  • Tsafrir A., Brautbar C., Nagler A., Elchalal U., Miller K. and Bishara A. 2000. Alloreactivity of umbilical cord blood mono-nuclear cells: specific hyporesponse to noninherited maternal antigens. Human Immunology 61: 548–554.

    Google Scholar 

  • Yap C., Loh M.T., Heng K.K., Tan P., Yu S.L., Chan S.H. and Ren E.C. 2000. Variability in CD34-cell counts in umbilical cord blood: implications for cord blood transplants. Gynecologic and Obstetric Investigation 50: 258–259.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arnon Nagler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, Y., Kreiser, D., Mayorov, M. et al. Unrelated and related cord blood banking and hematopoietic graft engineering. Cell Tissue Banking 4, 29–35 (2003). https://doi.org/10.1023/A:1026379514314

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026379514314

Navigation